Susan Chen

Viva Biotech

BIOGRAPHY

Dr. Susan Chen is the Chief Technology Officer of the PPO division at Viva Biotech, overseeing peptide, protein, and oligonucleotide platforms from early discovery through CDMO manufacturing. Professional experience includes senior leadership roles at organizations such as Chempartner, WuXi STA, Sinopep, and AmbioPharm, supporting complex drug development programs.

Susan leads technology strategy across peptide and oligonucleotide development, guiding CMC planning, complex peptide synthesis, scale-up, and commercialization while supporting the advancement of numerous investigational and approved therapeutic programs.